Selected research
Market Structure
Global Artemisinin and Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Artemisinin and Derivatives market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Artemisinin and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Artemisinin and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Artemisinin and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Artemisinin and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Artemisinin and Derivatives include Ipca Laboratories, Guilin Nantang Pharmaceutical, KPC Pharmaceuticals, Chongqing Kerui Nanhai Pharmaceutical, Sichuan Xieli Pharmaceutical, Cerata Pharmaceuticals and Aqre Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Artemisinin and Derivatives output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Artemisinin and Derivatives by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Artemisinin and Derivatives market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Artemisinin and Derivatives and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Artemisinin and Derivatives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artemisinin and Derivatives market size, projected growth trends, production technologies, key applications, and end-use industries.
Artemisinin and Derivatives Segment by Company
Ipca Laboratories
Guilin Nantang Pharmaceutical
KPC Pharmaceuticals
Chongqing Kerui Nanhai Pharmaceutical
Sichuan Xieli Pharmaceutical
Cerata Pharmaceuticals
Aqre Group
Artemisinin and Derivatives Segment by Type
Artemether
Artesunate
Artemisinin
Dihydroartemisinin
Artemisinin and Derivatives Segment by Application
Antitumor and Anti-inflammatory Drugs
Antimalarial Drugs
Artemisinin and Derivatives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artemisinin and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin and Derivatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Artemisinin and Derivatives market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artemisinin and Derivatives industry.
Chapter 3: Detailed analysis of Artemisinin and Derivatives market competition landscape. Including Artemisinin and Derivatives manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Artemisinin and Derivatives by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Artemisinin and Derivatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Artemether
- Artesunate
- Artemisinin
- Dihydroartemisinin
Applications
- Antitumor and Anti-inflammatory Drugs
- Antimalarial Drugs
Companies covered
- Ipca Laboratories
- Guilin Nantang Pharmaceutical
- KPC Pharmaceuticals
- Chongqing Kerui Nanhai Pharmaceutical
- Sichuan Xieli Pharmaceutical
- Cerata Pharmaceuticals
- Aqre Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Artemisinin and Derivatives Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Artemisinin and Derivatives Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Artemisinin and Derivatives Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Artemisinin and Derivatives Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Artemisinin and Derivatives Market Dynamics
- 2.1 Artemisinin and Derivatives Industry Trends
- 2.2 Artemisinin and Derivatives Industry Drivers
- 2.3 Artemisinin and Derivatives Industry Opportunities and Challenges
- 2.4 Artemisinin and Derivatives Industry Restraints
3 Artemisinin and Derivatives Market by Manufacturers
- 3.1 Global Artemisinin and Derivatives Production Value by Manufacturers (2021-2026)
- 3.2 Global Artemisinin and Derivatives Production by Manufacturers (2021-2026)
- 3.3 Global Artemisinin and Derivatives Average Price by Manufacturers (2021-2026)
- 3.4 Global Artemisinin and Derivatives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Artemisinin and Derivatives Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Artemisinin and Derivatives Manufacturers, Product Type & Application
- 3.7 Global Artemisinin and Derivatives Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Artemisinin and Derivatives Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Artemisinin and Derivatives Players Market Share by Production Value in 2025
- 3.8.3 2025 Artemisinin and Derivatives Tier 1, Tier 2, and Tier 3
4 Artemisinin and Derivatives Market by Type
- 4.1 Artemisinin and Derivatives Type Introduction
- 4.1.1 Artemether
- 4.1.2 Artesunate
- 4.1.3 Artemisinin
- 4.1.4 Dihydroartemisinin
- 4.2 Global Artemisinin and Derivatives Production by Type
- 4.2.1 Global Artemisinin and Derivatives Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Artemisinin and Derivatives Production by Type (2021-2032)
- 4.2.3 Global Artemisinin and Derivatives Production Market Share by Type (2021-2032)
- 4.3 Global Artemisinin and Derivatives Production Value by Type
- 4.3.1 Global Artemisinin and Derivatives Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Artemisinin and Derivatives Production Value by Type (2021-2032)
- 4.3.3 Global Artemisinin and Derivatives Production Value Market Share by Type (2021-2032)
5 Artemisinin and Derivatives Market by Application
- 5.1 Artemisinin and Derivatives Application Introduction
- 5.1.1 Antitumor and Anti-inflammatory Drugs
- 5.1.2 Antimalarial Drugs
- 5.2 Global Artemisinin and Derivatives Production by Application
- 5.2.1 Global Artemisinin and Derivatives Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Artemisinin and Derivatives Production by Application (2021-2032)
- 5.2.3 Global Artemisinin and Derivatives Production Market Share by Application (2021-2032)
- 5.3 Global Artemisinin and Derivatives Production Value by Application
- 5.3.1 Global Artemisinin and Derivatives Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Artemisinin and Derivatives Production Value by Application (2021-2032)
- 5.3.3 Global Artemisinin and Derivatives Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Ipca Laboratories
- 6.1.1 Ipca Laboratories Company Information
- 6.1.2 Ipca Laboratories Business Overview
- 6.1.3 Ipca Laboratories Artemisinin and Derivatives Production, Value and Gross Margin (2021-2026)
- 6.1.4 Ipca Laboratories Artemisinin and Derivatives Product Portfolio
- 6.1.5 Ipca Laboratories Recent Developments
- 6.2 Guilin Nantang Pharmaceutical
- 6.2.1 Guilin Nantang Pharmaceutical Company Information
- 6.2.2 Guilin Nantang Pharmaceutical Business Overview
- 6.2.3 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Production, Value and Gross Margin (2021-2026)
- 6.2.4 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Product Portfolio
- 6.2.5 Guilin Nantang Pharmaceutical Recent Developments
- 6.3 KPC Pharmaceuticals
- 6.3.1 KPC Pharmaceuticals Company Information
- 6.3.2 KPC Pharmaceuticals Business Overview
- 6.3.3 KPC Pharmaceuticals Artemisinin and Derivatives Production, Value and Gross Margin (2021-2026)
- 6.3.4 KPC Pharmaceuticals Artemisinin and Derivatives Product Portfolio
- 6.3.5 KPC Pharmaceuticals Recent Developments
- 6.4 Chongqing Kerui Nanhai Pharmaceutical
- 6.4.1 Chongqing Kerui Nanhai Pharmaceutical Company Information
- 6.4.2 Chongqing Kerui Nanhai Pharmaceutical Business Overview
- 6.4.3 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Production, Value and Gross Margin (2021-2026)
- 6.4.4 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Product Portfolio
- 6.4.5 Chongqing Kerui Nanhai Pharmaceutical Recent Developments
- 6.5 Sichuan Xieli Pharmaceutical
- 6.5.1 Sichuan Xieli Pharmaceutical Company Information
- 6.5.2 Sichuan Xieli Pharmaceutical Business Overview
- 6.5.3 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Production, Value and Gross Margin (2021-2026)
- 6.5.4 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Product Portfolio
- 6.5.5 Sichuan Xieli Pharmaceutical Recent Developments
- 6.6 Cerata Pharmaceuticals
- 6.6.1 Cerata Pharmaceuticals Company Information
- 6.6.2 Cerata Pharmaceuticals Business Overview
- 6.6.3 Cerata Pharmaceuticals Artemisinin and Derivatives Production, Value and Gross Margin (2021-2026)
- 6.6.4 Cerata Pharmaceuticals Artemisinin and Derivatives Product Portfolio
- 6.6.5 Cerata Pharmaceuticals Recent Developments
- 6.7 Aqre Group
- 6.7.1 Aqre Group Company Information
- 6.7.2 Aqre Group Business Overview
- 6.7.3 Aqre Group Artemisinin and Derivatives Production, Value and Gross Margin (2021-2026)
- 6.7.4 Aqre Group Artemisinin and Derivatives Product Portfolio
- 6.7.5 Aqre Group Recent Developments
7 Global Artemisinin and Derivatives Production by Region
- 7.1 Global Artemisinin and Derivatives Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Artemisinin and Derivatives Production by Region (2021-2032)
- 7.2.1 Global Artemisinin and Derivatives Production by Region (2021-2026)
- 7.2.2 Global Artemisinin and Derivatives Production Forecast by Region (2027-2032)
- 7.3 Global Artemisinin and Derivatives Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Artemisinin and Derivatives Production Value by Region (2021-2032)
- 7.4.1 Global Artemisinin and Derivatives Production Value by Region (2021-2026)
- 7.4.2 Global Artemisinin and Derivatives Production Value by Region (2027-2032)
- 7.5 Global Artemisinin and Derivatives Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Artemisinin and Derivatives Production Value (2021-2032)
- 7.6.2 Europe Artemisinin and Derivatives Production Value (2021-2032)
- 7.6.3 Asia-Pacific Artemisinin and Derivatives Production Value (2021-2032)
- 7.6.4 South America Artemisinin and Derivatives Production Value (2021-2032)
- 7.6.5 Middle East & Africa Artemisinin and Derivatives Production Value (2021-2032)
8 Global Artemisinin and Derivatives Consumption by Region
- 8.1 Global Artemisinin and Derivatives Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Artemisinin and Derivatives Consumption by Region (2021-2032)
- 8.2.1 Global Artemisinin and Derivatives Consumption by Region (2021-2026)
- 8.2.2 Global Artemisinin and Derivatives Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Artemisinin and Derivatives Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Artemisinin and Derivatives Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Artemisinin and Derivatives Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Artemisinin and Derivatives Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Artemisinin and Derivatives Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Artemisinin and Derivatives Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Artemisinin and Derivatives Value Chain Analysis
- 9.1.1 Artemisinin and Derivatives Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Artemisinin and Derivatives Production Mode & Process
- 9.2 Artemisinin and Derivatives Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Artemisinin and Derivatives Distributors
- 9.2.3 Artemisinin and Derivatives Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst